Latest debt-to-equity ratio
Kalaris Therapeutics Debt-to-equity ratio
Direct answer
Kalaris Therapeutics's debt-to-equity ratio is 2.43%.
The verified market snapshot reports 2.43%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 14, 2026.
Get free Kalaris Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 2.43%
Explore related company data
View Kalaris Therapeutics's market capitalizationView Kalaris Therapeutics's price-to-book ratioView Kalaris Therapeutics's return on equityView Kalaris Therapeutics's dividend yieldView Kalaris Therapeutics's 52-week price rangeView Kalaris Therapeutics's profit marginView all Kalaris Therapeutics key metricsReturn to Kalaris Therapeutics profile